People

Overview

Christopher Wilson is a partner in Baker Botts' Antitrust and Competition Practice group. His practice focuses on civil antitrust, intellectual property, and other complex commercial actions. Mr. Wilson has extensive experience representing both defendants and plaintiffs in federal and state courts from complaint filing through trial, as well as in advising corporate clients on a variety of antitrust and compliance matters. He has represented and advised clients across a range of industries, including but not limited to industrial manufacturing, telecommunications, pharmaceuticals, retail, and healthcare manufacturing.

Mr. Wilson leads legal teams for Fortune 500 clients that are defending against and asserting Sherman Act claims in class action and other civil litigation. He also has extensive experience defending pharmaceutical companies in patent infringement and antitrust actions, as well as representing generic pharmaceutical manufacturers in Hatch-Waxman Act litigation.

Mr. Wilson has served as co-chair of the ABA Section of Litigation's Antitrust Litigation and Consumer Litigation Committees. He currently serves as a member of the External Advisory Board for the Schreyer Honors College at Penn State University.

Mr. Wilson graduated from Stanford Law School, where he served as President of the Stanford Black Law Students Association and participated in legal clinics directed to criminal defense and public education law. He received his undergraduate degree from Penn State, where he was a Schreyer Honors Scholar and played running back and fullback for the university's football team.

Admission & Affiliations

  • District of Columbia Bar
  • Illinois State Bar
  • United States Courts of Appeals for the Third and Eleventh Circuits
  • United States District Court for the Northern District of Illinois
  • J.D., Stanford Law School 2012
  • B.A., Political Science, Pennsylvania State University 2006
    with honors

Experience

  • Representing major grocer and distributor in asserting antitrust claims in multi-district litigations directed to multi-billion dollar consumer sectors.
  • Representing major pharmaceutical company in in antitrust class action involving a blockbuster biologic drug, where class plaintiffs have alleged reverse-payment settlement agreements between the brand and biosimilar manufacturers, and also that the brand amassed a "patent thicket" of over 100 patents that forestalled competition.
  • Representing major generic pharmaceutical companies in one of the largest-ever antitrust class actions, currently pending as multi-district litigation brought by state attorneys general, individual, direct action plaintiffs, and putative classes of direct, intermediate, and end purchaser plaintiffs.
  • Representing major generic pharmaceutical company in antitrust action brought in involving alleged sham litigation and misuse of Hatch-Waxman regulatory scheme.
  • Represented industrial manufacturer in a class action alleging a Section 1 price-fixing conspiracy;  granted a favorable ruling on summary judgment, which was affirmed on appeal.
  • Represented healthcare manufacturers in a class action alleging a Section 1 price-fixing conspiracy; granted a favorable judgment on a motion to dismiss the original consolidated complaint.
  • Represented generic pharmaceutical manufacturers in Hatch-Waxman Act litigation; was deeply involved in negotiating settlements as well as in representing clients through trial.
  • Represented manufacturer in a civil action that initially asserted antitrust and various common law claims; the plaintiff voluntarily dismissed the antitrust claim rather than responding to a motion to dismiss directed to that claim.
  • Represented a mother and child in a pro bono action against a state department of family services, alleging violations of the mother's and child's constitutional rights; granted a six-figure monetary settlement for the mother and child, as well as extensive policy changes within the state department.

Awards and Community

Recognized as a "Rising Star" by The Legal 500 U.S., 2022 & 2023

Recognized as a Washington D.C. Super Lawyer-Rising Star (Thomson Reuters), 2022